Mullen Announces New CARB Approval for 2025 Class 3 EV Cab Chassis Truck
April 25, 2024 09:15 ET
|
Mullen Automotive, Inc.
Company now in receipt of CARB approval for both 2024 and 2025 Class 3 Model Years CARB certification takes on even more significance with the recent Advanced Clean Fleets (“ACF”) regulation,...
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
April 25, 2024 09:15 ET
|
GRI Bio, Inc.
Live webcast on Wednesday, May 1st at 3:00 PM ET LA JOLLA, CA, April 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
April 25, 2024 09:14 ET
|
Aclarion, Inc.
LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a single-payer national health insurance system ...
New Research Reveals Influencers Significantly Drive Purchasing Decisions
April 25, 2024 09:03 ET
|
Sprout Social, Inc
CHICAGO, April 25, 2024 (GLOBE NEWSWIRE) -- Influencers have cemented themselves as key components of modern marketing strategies, and new research reveals the significant power they have in...
Varonis at RSAC 2024: Reducing AI's Blast Radius and Deploying Copilots Safely
April 25, 2024 09:00 ET
|
Varonis Systems, Inc.
Varonis released its full event schedule as a Platinum Plus Sponsor of the RSA Conference 2024.
Calavo Growers, Inc. Provides Update to Shareholders
April 25, 2024 09:00 ET
|
Calavo Growers, Inc.
Calavo Growers, Inc. (Nasdaq: CVGW) provides update to shareholders following its Annual Meeting of Shareholders
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 25, 2024 09:00 ET
|
INmune Bio, Inc.
Boca Raton, Florida, April 25, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
April 25, 2024 09:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Precision Optics Announces Receipt of $1.26 Million Follow On Production Order from Large Defense Company
April 25, 2024 09:00 ET
|
Precision Optics Corporation
GARDNER, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense...
Vital Farms to Report First Quarter 2024 Financial Results on May 9, 2024
April 25, 2024 09:00 ET
|
Vital Farms
AUSTIN, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, will report financial results for...